+49 711 500 989 80
deen

Targeting interleukin-6 could help relieve immunotherapy side effects



Targeting interleukin-6 could help relieve immunotherapy side effects

Researchers have identified a novel strategy to reduce immune-related adverse events from immunotherapy treatment by targeting the cytokine interleukin-6 (IL-6).

Materials provided by University of Texas M. D. Anderson Cancer Center. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

20th May 2022

Killer T vs. memory — DNA isn't destiny for T cells

Read more
19th May 2022

Epilepsy drug stops nervous system tumor growth in mice

Read more
19th May 2022

Researchers find another layer to the code of life

Read more